Document is current
Any future updates will be listed below
-
Authors
Yang, Yaru
Qiu, Hongyan
Fan, Yuru
Zhang, Qin
Qin, Huiling
Wu, Juan
Zhang, Xuan
Liu, Yueyue
Zhou, Renpeng
Zhang, Qian
Ye, Zi
Ma, Jingyue
Xu, Ye
Feng, Sheng
Fei, Yue
Li, Na
Cui, Xiaojing
Dong, Fangli
Wang, Quanren
Shen, Kai
Shakib, Sepehr
Williams, Jasmine
Hu, Wei
- License Information
-
More Information
Article History
Received: 29 November 2023
Accepted: 29 September 2024
First Online: 10 October 2024
Declarations
:
: The studies were performed in accordance with the ethical principles of Declaration of Helsinki, Good Clinical Practice guidelines, and local regulatory requirements. The study protocol was approved by the institutional review board of the Second Affiliated Hospital of Anhui Medical University (China) and the Bellberry Human Research Ethics Committee (Australia). All participants provided written informed consent.
: Not applicable.
: HQiu, ZY, JM, YX, SF, YFei, NL, XC, FD, QW, and KS were employees of Jiangsu Hengrui Pharmaceuticals at the time of study. All other authors have no conflicts of interest to declare.
